Di-Methyl-Histone H4 (Lys20) Antibody

Di-Methyl-Histone H4 (Lys20) A

ntibody
收藏
  • 询价
  • Cell Signaling Technology已认证
  • USA
  • 2025年11月21日
  • W
  • Rabbit
  • H,M,R,Mk,Dm,Z,B,Pg,Hr,Ce
avatar
品牌商
12钻石会员
  • 企业认证

    • 详细信息
    • 技术资料
    • 抗体英文名

      Di-Methyl-Histone H4 (Lys20) Antibody

    • 抗原

      synthetic peptide corresponding to the amino terminus of histone H4 in which lysine 20 is di-methylated

    • 应用范围

      W

    • 宿主

      Rabbit

    • 级别

      详见MSDS文件

    • 供应商

      CST

    • 库存

      大量

    • 保质期

      详见说明书

    • 适应物种

      H,M,R,Mk,Dm,Z,B,Pg,Hr,Ce

    • 是否单克隆

      2

    • 保存条件

      -20°c

    • 规格

      100 ul (10 western blots)/carrier free & custom formulation / quantity

    规格:产品价格:¥请询价
    规格:100 ul (10 western blots)产品价格:¥请询价
    规格:carrier free & custom formulation / quantity产品价格:¥请询价

    pathway more info application references datasheet PDF MSDS PDF protocols

    Applications Key:  W=Western Blotting
    Reactivity Key:  H=Human  M=Mouse  R=Rat  Mk=Monkey  Dm=D. melanogaster  Z=Zebrafish  B=Bovine  Pg=Pig  Hr=Horse  Ce=C. elegans
    Species cross-reactivity is determined by western blot. Species enclosed in parentheses are predicted to react based on 100% sequence homology.

    Applications Reactivity Sensitivity MW (kDa) Source
    W H M R Mk (Dm) (Z) (B) (Pg) (Hr) (Ce) Endogenous 11 Rabbit
    Protocols
    Specificity / Sensitivity

    Di-Methyl-Histone H4 (Lys20) Antibody detects endogenous levels of histone H4 only when di-methylated on Lys20. The antibody does not cross-react with non-, mono- or tri-methylated Lys20. In addition, the antibody does not cross-react with mono-, di- or tri-methylated histone H3 at Lys4, Lys9, Lys27 or Lys36.

    Source / Purification

    Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to the amino terminus of histone H4 in which lysine 20 is di-methylated. Antibodies are purified by protein A and peptide affinity chromatography.

    Western Blotting

    Western Blotting

    Western blot analysis of extracts from various cell lines using Di-Methyl-Histone H4 (Lys20) Antibody.

    ELISA-Peptide

    ELISA-Peptide

    Di-Methyl-Histone H4 (Lys20) Antibody specificity was determined by peptide ELISA. The graph depicts the binding of the antibody to pre-coated di-methyl histone H4 (Lys20) peptide in the presence of increasing concentrations of various competitor peptides. As shown, only the di-methyl histone H4 (Lys20) peptide competed away binding of the antibody.

    Background

    The nucleosome, made up of four core histone proteins (H2A, H2B, H3, and H4), is the primary building block of chromatin. Originally thought to function as a static scaffold for DNA packaging, histones have now been shown to be dynamic proteins, undergoing multiple types of post-translational modifications, including acetylation, phosphorylation, methylation, and ubiquitination (1). Histone methylation is a major determinant for the formation of active and inactive regions of the genome and is crucial for the proper programming of the genome during development (2,3). Arginine methylation of histones H3 (Arg2, 17, 26) and H4 (Arg3) promotes transcriptional activation and is mediated by a family of protein arginine methyltransferases (PRMTs), including the co-activators PRMT1 and CARM1 (PRMT4) (4). In contrast, a more diverse set of histone lysine methyltransferases has been identified, all but one of which contain a conserved catalytic SET domain originally identified in the Drosophila Su(var)3-9, Enhancer of zeste, and Trithorax proteins. Lysine methylation occurs primarily on histones H3 (Lys4, 9, 27, 36, 79) and H4 (Lys20) and has been implicated in both transcriptional activation and silencing (4). Methylation of these lysine residues coordinates the recruitment of chromatin modifying enzymes containing methyl-lysine binding modules such as chromodomains (HP1, PRC1), PHD fingers (BPTF, ING2), tudor domains (53BP1), and WD-40 domains (WDR5) (5-8). The discovery of histone demethylases such as PADI4, LSD1, JMJD1, JMJD2, and JHDM1 has shown that methylation is a reversible epigenetic marker (9).

    1. Peterson, C.L. and Laniel, M.A. (2004) Curr. Biol. 14, R546-R551.
    2. Kubicek, S. et al. (2006) Ernst Schering Res. Found Workshop , 1-27.
    3. Lin, W. and Dent, S.Y. (2006) Curr. Opin. Genet. Dev. 16, 137-142.
    4. Lee, D.Y. et al. (2005) Endocr. Rev. 26, 147-170.
    5. Daniel, J.A. et al. (2005) Cell Cycle 4, 919-926.
    6. Shi, X. et al. (2006) Nature 442, 96-99.
    7. Wysocka, J. et al. (2006) Nature 442, 86-90.
    8. Wysocka, J. et al. (2005) Cell 121, 859-872.
    9. Trojer, P. and Reinberg, D. (2006) Cell 125, 213-217.
    Application References

    Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know !

    Companion Products

    For Research Use Only. Not For Use In Diagnostic Procedures.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥3662
    上海瑶韵生物科技有限公司
    2025年05月19日询价
    ¥4420
    杭州囊萤科技有限公司
    2025年05月22日询价
    ¥3662
    北京智杰方远科技有限公司
    2025年06月25日询价
    询价
    美国CST中国公司(丁香通商铺)
    2024年10月03日询价
    询价
    赛默飞世尔科技
    2025年07月03日询价
    Di-Methyl-Histone H4 (Lys20) Antibody
    询价